WuXi Biologics (2269.HK)
|Gross Profit (TTM)||HK$4.83B|
|Year Range||HK$35.00 - HK$87.00|
Share Price Chart
The chart shows the growth of an initial investment of HK$10,000 in WuXi Biologics, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
WuXi Biologics had a return of -28.24% year-to-date (YTD) and -20.90% in the last 12 months. Over the past 10 years, WuXi Biologics had an annualized return of 29.78%, outperforming the S&P 500 benchmark which had an annualized return of 9.37%.
|5 years (annualized)||8.39%||8.42%|
|10 years (annualized)||29.78%||9.37%|
Monthly Returns Heatmap
This table presents a comparison of risk-adjusted performance metrics for WuXi Biologics (2269.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
|Sharpe ratio||Sortino ratio||Omega ratio||Calmar ratio||Ulcer Index|
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the WuXi Biologics. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the WuXi Biologics is 75.62%, recorded on Oct 31, 2022. The portfolio has not recovered from it yet.
|-75.62%||Jun 29, 2021||332||Oct 31, 2022||—||—||—|
|-52.19%||Jun 11, 2018||141||Jan 3, 2019||235||Dec 16, 2019||376|
|-35.01%||Feb 16, 2021||15||Mar 8, 2021||57||Jun 1, 2021||72|
|-25.31%||Mar 12, 2020||6||Mar 19, 2020||32||May 8, 2020||38|
|-17.74%||Apr 12, 2018||16||May 4, 2018||17||May 30, 2018||33|
The current WuXi Biologics volatility is 11.96%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.